Healthscore 576·6 metrosupdated 4h ago
FDA Panel Reviews Moderna's mRNA Flu Vaccine for Older Adults
U.S. health advisers are considering Moderna's mFlusiva, an mRNA-based flu vaccine aimed at adults 50 and older. This innovative vaccine could provide a faster response to flu mutations, potentially saving lives as the winter season approaches.
Where it's breaking
Local coverage
FDA Panel Reviews Moderna's mRNA Flu Vaccine for Older Adults
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
FDA Panel Reviews First mRNA Flu Vaccine for Older Adults
FDA panel considers a first-of-its-kind flu vaccine using mRNA technology
Sources cited
Original outlets that filed on this story across the contributing metros. Click through for the underlying coverage.
What this is
A national rollup is a story Executive Producer detected breaking in multiple US metros at once. Each contributing market has its own deduplicated cluster from local broadcast, print, government, and community sources — this page links them together so a journalist can see the full national footprint. We are a pointer, not a publisher.Every linked headline goes back to the local cluster and from there to the original outlet — that's the URL to cite. A lead, not the law.